Dataset from ACCENT I - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long-term Treatment of Patients With Moderately to Severely Active Crohn's Disease

Name: Dataset from ACCENT I - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long-term Treatment of Patients With Moderately to Severely Active Crohn's Disease
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://doi.org/10.25934/00004618

下载链接

链接失效反馈

官方服务：

资源简介：

This is a study of infliximab (Remicade) in subjects with Crohn's disease

创建时间：

2026-03-02